<DOC>
	<DOCNO>NCT00508742</DOCNO>
	<brief_summary>This study design assess impact 13-valent Pneumococcal Conjugate Vaccine ( 13vPnC ) nasopharyngeal colonization Streptococcus pneumoniae healthy infant .</brief_summary>
	<brief_title>Study Evaluating Impact 13-valent Pneumococcal Conjugate Vaccine Nasopharyngeal Colonization</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infant age 2 month ( 4298 day ) time enrolment . Available entire study period whose parent/legal guardian reach telephone . Previous vaccination license investigational pneumococcal vaccine . A previous anaphylactic reaction vaccine vaccinerelated component . Contraindication vaccination pneumococcal conjugate vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Nasopharyngeal Colonization</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Healthy Infants</keyword>
	<keyword>Vaccines</keyword>
	<keyword>Pneumococcal Conjugate Vaccine</keyword>
</DOC>